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ABSTRACT: The ligand binding site of Cys-loop receptors is dominated by
aromatic amino acids. In GABAC receptors, these are predominantly tyrosine
residues, with a number of other aromatic residues located in or close to the
binding pocket. Here we examine the roles of these residues using substitution
with both natural and unnatural amino acids followed by functional
characterization. Tyr198 (loop B) has previously been shown to form a
cation−π interaction with GABA; the current data indicate that none of the
other aromatic residues form such an interaction, although the data indicate
that both Tyr102 and Phe138 may contribute to stabilization of the positively
charged amine of GABA. Tyr247 (loop C) was very sensitive to substitution
and, combined with data from a model of the receptor, suggest a π−π
interaction with Tyr241 (loop C); here again functional data show aromaticity
is important. In addition the hydroxyl group of Tyr241 is important,
supporting the presence of a hydrogen bond with Arg104 suggested by the model. At position Tyr102 (loop D) size and
aromaticity are important; this residue may play a role in receptor gating and/or ligand binding. The data also suggest that
Tyr167, Tyr200, and Tyr208 have a structural role while Tyr106, Trp246, and Tyr251 are not critical. Comparison of the agonist
binding site “aromatic box” across the superfamily of Cys-loop receptors reveals some interesting parallels and divergences.
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T
he agonist binding sites of all Cys-loop receptors are rich
in aromatics, and the crystal structure of AChBP,
1 a nACh
receptor subunit,
2 the prokaryotic homologues ELIC and
GLIC,
3−5 and the recently published GluCl structure
6 all reveal
a cluster of aromatic residues, the so-called “aromatic box”,
which, in vertebrate receptors at least, encapsulates the agonist.
One of these aromatic box residues has been shown to have a
cation−π interaction with the natural agonist in most Cys-loop
receptors studied to date, and the importance of such an
interaction in this protein family is well-established.
7 However,
apart from this particular aromatic residue, information about
the roles of the aromatic residues is scarce. This is of
considerable interest as such studies provide essential
information for verifying lower resolution structural data, and
also for modeling and docking studies.
GABA, the major inhibitory neurotransmitter in the
mammalian CNS, mediates its effects via ionotropic (GABAA
or GABAC) and metabotropic (GABAB) receptors. GABAC
receptors, which are constituted from ρ subunits,
8 are a subclass
of GABAA receptors, to which they have strong structural and
functional similarities. GABAC receptors, however, have distinct
pharmacological properties: GABAC receptor-mediated re-
sponses are not inhibited by bicuculline (the classic competitive
GABAA receptor antagonist) nor induced by baclofen (the
classic GABAB receptor agonist). Thus, there are clearly some
significant differences in the microstructures of these different
GABA binding sites.
A model of the GABAC receptor binding site, based on the
structure of the acetylcholine binding protein AChBP, indicates
that the site is dominated by aromatic amino acids.
9 This is to
be expected, as all Cys-loop receptor binding pockets contain a
high proportion of aromatic amino acids.
10 However, the
GABAC receptor is unusual in that there are no tryptophan
residues in the binding pocket; where Trp is positioned in
related nACh, 5-HT3 and MOD-1 receptor binding sites, it has
been replaced by Tyr in the GABAC receptor (Figure 1; Table
1). Experimental data to date indicate that the model is
relatively accurate, but, as it is generated from a homologous
protein, it has a number of limitations and some aspects will be
inaccurate. Thus, it is important to use experimental evidence
to prove or disprove specific details.
We have previously established that GABA makes a potent
cation−π interaction to Tyr198 on binding to the GABAC
receptor.
11 This is the residue that aligns with a Trp that has a
similar interaction in nACh and 5-HT3 receptors,
12,13 and was
the first case in which a tyrosine was shown to play this role.
Cation−π interactions are increasingly being appreciated as
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ligand interactions, and, as more proteins structures are being
revealed at atomic resolution, we have an ever increasing
understanding of how and where these interactions are
formed.
7 It has long been known that Trp will form an
energetically more favorable cation-π interaction than Tyr, and
indeed it is clear from earlier studies on Cys-loop receptors that
a Trp is preferred over a Tyr when there is a choice between
them: In the MOD-1 receptor, where the Trp that forms a
cation−π interaction with 5-HT has been replaced with a Tyr,
and a Tyr that is located 8−10 Å distant on the other side of
the binding pocket has been replaced with a Trp, 5-HT will
now form a cation−π interaction with the Trp.
14 There is no
Trp in the GABAC binding pocket, but the recent model of the
binding pocket of the GABAC receptor shows that four Tyr
residues are within 5 Å of the amino group of GABA (Figure
2). Since it is well-established that multiple π systems can make
cation−π interactions to a single cation,
7,15 and recently two
aromatic residues have been shown to contribute to such an
interaction in an insect GABA receptor,
16 one of the aims of
this study was to probe this possibility in the GABAC receptor.
We also explore the roles of other aromatics in or close to the
binding site, and compare and contrast the roles these residues
play with analogous residues in other Cys-loop receptors.
Figure 1. Sequence alignments for the ligand binding domain of the GABAC and other Cys loop receptor subunits. Residues with similar chemical
properties are shaded. The approximate locations of the loops that constitute the binding pocket are indicated with black bars. Those residues
examined in this study are stared.
Table 1. Alignment of Residues Contributing to the
Aromatic Box in Different Cys-Loop Receptors
a
loop C
receptor loop A loop B C1 C2 loop D ref
nACh Y93 W149 Y190 Y198 W55 13
5-HT3 F130 W183 F226 F234 W90 12
MOD-1 C120 Y180 Y221 W226 F83 14
GABAA Y97 Y157 F200 Y205 F65 19
GABAC F138 Y198 Y241 Y247 Y102 11
RDL F146 F206 L249 Y254 Y109 16
Glycine F99 F159 Y202 F207 F63 24
aResidues in bold have been shown to be involved in cation−π
interactions with agonists.
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Functional Studies of GABAC Receptors. Xenopus
oocytes injected with WT GABAC cRNA showed robust
responses to GABA application, and dose−response curves
revealed an EC50 of 1.4 ± 0.2 μM, and Hill coefficient of 1.6 ±
0.3 (n = 4). These data are in good agreement with those
previously published.
17 For validation of the nonsense
suppression technique, tyrosine was incorporated via acylated
tRNA at each of the four positions being examined. Thus,
mRNAs synthesized from TAG-containing mutants, when
coinjected into Xenopus oocytes with tRNA-Tyr molecules,
produced functional receptors that responded to application of
GABA with similar EC50 values and Hill coefficients to WT
receptors. Thus, the wild type phenotype was successfully
“rescued” by the delivery of tRNA-Tyr molecules. For each
receptor, maximal GABA-induced currents (Imax) were typically
0.4−1 μA at a holding potential of −60 mV (see examples in
Figure 3). Since conventional expression of wild type GABAC
receptors typically gives 3−5 μA currents, this suggests that the
efficiency of nonsense suppression is probably close to 10−
20%, similar to the value estimated for this technique from
suppression of nACh receptors.
18
The Role of the Loop A Phenylalanine Residue. The
canonical aromatic box in Cys-loop receptors is formed from
five residues on loops A, B, C (principal subunit), and D
(complementary subunit) (Table 1). The alignment of loop A
across the Cys-loop family is challenging (e.g., see ref 19), but
we considered Phe138 to align with the aromatic in loop A.
The data indicate that an aromatic is important but not critical
at this location. The change in EC50 when this is substituted
with Ala (∼30-fold) is small compared to the same substitution
in the Tyr residues that contribute to the aromatic box in loops
B, C, and D (>100 fold EC50 increases; Table 2), indicating that
aromaticity is less critical here. Nevertheless, we propose that
an aromatic here may contribute to stabilization of the
positively charged amine.
The Role of the Loop B Tyrosine Residue. We have
previously shown that Tyr198, the loop B residue of the
aromatic box, makes a strong cation−π interaction to GABA.
11
Consistent with this role for Tyr198, we found that substitution
of Tyr198 with Phe or 4-MeO-Phe was reasonably well
tolerated (<10 fold increase in EC50) while changing this
residue to Ala or Ser was not, causing ∼1400- or ∼4000-fold
increases in EC50, respectively (Table 3). Incorporation of Trp
showed a ∼180 fold increase in EC50. Replacements of Tyr198
with 4-F-Phe, 3,5-F2-Phe, and 3,4,5-F3-Phe have already been
reported and show substantial, incremental increases in EC50
with the addition of each F, demonstrating that this residue
forms a strong cation−π interaction with GABA.
11
The Role of the Loop C Tyrosine Residues. Tyr241 is
equivalent to αTyr190 in Torpedo nACh receptors, and both an
Figure 2. (A) Model of the GABAC receptor binding site showing
GABA docked into the binding pocket. For ease of viewing, only two
of the five subunits are shown. Inset: Enlargement of the binding
pocket showing GABA surrounded by aromatic binding site residues.
(B) The location of GABA docked into the GABAC receptor binding
pocket is consistent with a cation-π interaction at Y198 as previously
shown.
11 The model reveals there is also the potential for aromatic
stabilization of GABA by Tyr102 and Phe138, as suggested by the
data. The location of Arg104, which has previously been shown to be
critical for GABA binding, is also consistent with the presence of a
hydrogen bond with Tyr247 as suggested by the data.
Figure 3. (A) Typical responses to GABA application to mutant
GABAC receptors expressed in oocytes. (B) Typical concentration
response data from which the parameters in Tables 2 and 3 are
determined.
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binding and gating.
20 The data obtained from insertion of
alternative natural amino acids at this position suggest both of
these groups are also important in the GABAC receptor: Ala
and Ser substitutions cause large increases in EC50 (∼3600- and
∼1100-fold) while Phe (∼20-fold) and Trp (∼8-fold) have less
effect. Trp causes a smaller change to the EC50 than Phe,
suggesting that the role of the hydroxyl can perhaps be partially
fulfilled by Trp, although not by Br, F, Me, or MeO at the 4
position or hydroxyl at the 3 position. These data support the
model, which suggests a role for this hydroxyl: a hydrogen bond
with Arg104, a residue which has been previously shown to be
critical for GABA binding in this receptor.
21
Tyr247 was the most sensitive to substitution of the Tyr
residues in the GABAC receptor binding pocket, indicating its
importance. Our data show that aromaticity is critical:
functional receptors were only obtained when it was replaced
by Phe or Trp. The model suggests it may form a π−π
interaction with Tyr241, which could be important for defining
the structure of the C loop. In addition, the hydroxyl is
important at this location: replacement with Phe caused a large
increase (∼30-fold) in EC50. A main chain hydrogen bond with
Ala 199, as predicted by the model, can explain these data. The
increase in EC50 for Trp was ∼70-fold, suggesting that size is
also important at this position, a hypothesis that is again
supported by the model. This residue is conserved as an
aromatic residue throughout the Cys-loop family, and studies
on GABAA and 5-HT3 receptors have shown the equivalent
residue is critical for binding and/or gating (indeed in MOD-1
receptors, the equivalent residue Trp226 forms a cation−π
interaction with the agonist). We propose that its crucial role is
due to its specific interaction with surrounding residues that
control the location and structure of the C loop.
Tyr241 and Tyr247 are both on the C loop, and in these
locations are referred to as C1 and C2 respectively. In the
extensively investigated nAChRs, C1 is highly sensitive to
substitution, but C2 is quite permissive. Just the opposite
appears to be happening in the GABAC receptor, where a large
number of substitutions at C2 give nonfunctional receptors,
while many substituents are tolerated at C1. The C loop is the
most variable segment of the binding pocket between Cys loop
receptors, and these data further emphasize that this region is
not only constituted of different residues and is of different
lengths, but also that different sections play different roles in
the different receptors.
The Role of the Loop D Tyrosine Residue. Tyr102 is
contributed by the complementary subunit, and in the model of
GABA docked into the GABAC binding pocket it is ∼4 Å from
the primary amine, which would be close enough to provide
some aromatic character to help stabilize this group. Our data,
however, show no evidence for a cation−π interaction, although
it is clear that a small aromatic residue here is strongly
preferred: Phe, 4-F-Phe, 3,4,5-F3-Phe, 4-Me-Phe, and 4-Br-Phe
can substitute effectively for Tyr, while Ala or Ser substitution
result in ∼80- and ∼100-fold increases in EC50. Relocation of
the hydroxyl group, as in 3-OH-Phe, however, is deleterious, as
is an increase in size, such as with 4-MeO-Phe or Trp, which
result in ∼130- or ∼630-fold increases in EC50, respectively.
These data confirm the previous suggestion that aromaticity
and size are important at this position,
17 and these authors also
suggested that the residue at this location should be rigid:
substitution with Gly resulted in a ∼9000-fold increase in EC50.
A subsequent study
22 reported unusually high oocyte resting
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could be blocked by picrotoxin, indicating spontaneously open
channels. This residue is conserved as an aromatic across the
Cys-loop family, indicating an important role, and mutagenesis
in the GABAA receptor has demonstrated the homologous
residue (α1Phe64) both forms part of the core of the ligand
binding site, and is in a region (Asp162-Ser168) that appears to
move during gating.
23 Thus we conclude that an aromatic
residue at position 102 is important both for binding and/or
gating in GABAC receptors, but there is no direct contribution
to a cation-π interaction.
The Role of Other Aromatic Residues Located in or
Close to the Binding Site. Other aromatic residues which lie
in or close to the binding pocket are Tyr106, Tyr167, Tyr200,
Tyr208, Tyr251, and Trp246, (Figure 4). Tyr167 and Tyr208
are some distance from the binding pocket, but both were
sensitive to substitution by Ala; EC50's were increased ∼20-fold
(Tyr167) or resulted in nonfunctional receptors (Tyr208),
suggesting a structural role. We propose this involves
interactions with both the aromatic and the hydroxyl groups
at both locations, as retaining one of these, that is replacement
with Ser or Phe, caused only small or no changes in EC50.
Tyr200 faces away from the ligand, yet was very sensitive to
substitution: the only mutation that yielded functional
receptors was Y200F, which resulted in an ∼100-fold increase
in EC50, similar to data previously reported.
17 Thus, Tyr200
may have an important role in binding or gating, although this
may be secondary, such as ensuring Tyr198 is in the correct
orientation. Alternatively, this residue may have a purely
structural role, perhaps in receptor folding and/or for
stabilizing the structure of the B loop, which is a rigid structure
relative to which other regions of the binding pocket are
proposed to move during receptor activation.
24 Substituting
Tyr106, and also Tyr251, with Ala or Phe resulted in <6 fold
changes in EC50 compared to wild type receptors, indicating
that these residues also do not play important roles in the
function of the receptor; these residues are facing away from
the binding pocket in the model, supporting this hypothesis.
■ CONCLUSIONS
It has long been known that the binding site of all Cys-loop
receptors is dominated by aromatic amino acids. In the nACh,
5-HT3, MOD-1, GABAA/C glycine, and GluCl receptors one of
these amino acids has been shown to form a cation−π
interaction with agonist,
12−14,19,25 while two aromatics
contribute to this interaction in an insect GABA receptor.
16
Here we evaluate the roles of other aromatic residues in the
GABAC receptor binding pocket. We find evidence for a range
of interactions, but no other residue contributes to a cation−π
interaction. Interesting parallels and divergences are evident
when comparing the agonist binding site “aromatic box” across
the superfamily of Cys-loop receptors.
■ METHODS
Modeling and Ligand Docking. This was performed as
previously described.
9 Briefly the extracellular domain of the human
GABA ρ1 subunit sequence was aligned with the sequence of a
monomer of the AChBP using FUGUE,
26 and 3D models created
using MODELLER v 8.1
27 based on the crystal structure of AChBP
(PDB: 1UV6). The models were analyzed using RAMPAGE (de
Bakker and Lovell, http://raven.bioc.cam.ac.uk/rampage.php), and the
best model was considered to be the one with fewest amino acids in
unfavorable regions of the Ramachandran plot. A pentamer was
generated by superimposing the modified monomer onto each
monomer of the pentameric AChBP. The GABAC pentamer was
then energy minimized in SYBYL using the AMBER force field.
28
GABA was docked into the binding region of the GABAC receptor
using GOLD v 3.0 (Cambridge Crystallographic Data Centre).
Site-Directed Mutagenesis. Mutagenesis reactions were per-
formed using the method developed by Kunkel.
29 For nonsense
suppression, each of the tyrosine codons was replaced by TAG as
Table 3. Mutations at Tyr102, Tyr198, Tyr241, and Tyr247
a
Y102 Y198 Y241 Y247
residues EC50 (μM) nHE C 50 (μM) nHE C 50 (μM) nHE C 50 (μM) nH
Y(wild type) 1.4 ± 0.2 1.6 ± 0.3 1.4 ± 0.2 1.6 ± 0.3 1.4 ± 0.2 1.6 ± 0.3 1.4 ± 0.2 1.6 ± 0.3
F 1.9 ± 0.6 1.1 ± 0.3 12 ± 1
b 1.6 ± 0.1 21 ± 1
b 1.3 ± 0.1 42 ± 4
b 1.5 ± 0.2
A 110 ± 20
b 1.2 ± 0.2 2000 ± 200
b 1.1 ± 0.1 4900 ± 480
b 1.1 ± 0.1 NR
S 135 ± 25
b 1.3 ± 0.3 5600 ± 600
b 1.6 ± 0.2 1500 ± 96
b 1.2 ± 0.1 NR
W 860 ± 60
b 1.4 ± 0.1 250 ± 30
b 1.1 ± 0.1 8.2 ± 1.4
b 1.3 ± 0.3 99 ± 8
b 1.3 ± 0.1
4-F-Phe 3.1 ± 0.3 1.5 ± 0.2 34 ± 7
c 1.9 ± 0.3 1100 ± 370
b 0.6 ± 0.1
b 90 ± 3
b 1.9 ± 0.1
3,5-F2−Phe 6.1 ± 0.9
b 1.6 ± 0.3 1700 ± 400
c 1.4 ± 0.2 490 ± 190
b 1.5 ± 0.3 NR
3,4,5-F3-Phe 3.4 ± 0.5 1.3 ± 0.2 8400 ± 1000
c 1.5 ± 0.1 950 ± 140
b 1.3 ± 0.3 NR
4-Br-Phe 1.6 ± 0.8 1.3 ± 0.4 620 ± 30
b 1.8 ± 0.2 2900 ± 170
b 1.1 ± 0.1
4-Me-Phe 4.6 ± 2.1 1.4 ± 0.3 140 ± 100
b 1.4 ± 0.4 NR
4-MeO-Phe 180 ± 20
b 1.4 ± 0.2 6.6 ± 2
c 1.6 ± 0.2 530 ± 50
b 1.7 ± 0.2 NR
3-OH-Phe 66 ± 9
b 1.7 ± 0.3 350 ± 70
b 1.5 ± 0.4 NR
aData = mean ± SEM, n ≥ 3.
bSignificantly different to wild type, p < 0.05.
cPreviously published (ref 11).
Figure 4. Location of aromatic residues tested in this study that do not
directly contribute to the binding pocket on the principle (LHS) and
complementary (RHS) faces. The data show that Tyr167, Tyr200, and
Tyr208 are important for correct receptor function suggesting a role in
the structure and/or gating of the receptor.
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11 A silent restriction site was incorporated in
each to assist rapid identification.
Oocyte Preparation. Harvested stage V−VI Xenopus oocytes were
washed in four changes of OR2 (82.5 mM NaCl, 2 mM KCl, 1 mM
MgCl2, 5 mM HEPES, pH 7.5), defolliculated in 1 mg/mL collagenase
for approximately 1 h, washed again in four changes of OR2 and
transferred to 70% Leibovitz media (Gibco) buffered with 10 mM
HEPES, pH 7.5. The following day they were injected with 5 ng of
mRNA produced by in vitro transcription using the mMESSAGE
mMACHINE kit (Ambion) from DNA subcloned into pGEMHE as
previously described.
9 Electrophysiological measurements were
performed 24−72 h postinjection.
Synthesis of tRNA and dCA-Amino Acids. Unnatural amino
acids were chemically synthesized as nitroveratryloxycarbonyl
protected cyanomethyl esters and coupled to the dinucleotide dCA,
which was then enzymatically ligated to 74-mer THG73 tRNACUA as
detailed previously.
13 Immediately prior to coinjection with mRNA,
tRNA-aa was deprotected by photolysis. Typically 5 ng of mRNA and
25 ng of tRNA-aa were injected into Stage V−VI oocytes in a total
volume of 50 nL. For control experiments, mRNA was injected (1) in
the absence of tRNA and (2) with the THG73 74-mer tRNA.
Experiments were performed 18−72 h postinjection.
Electrophysiological Recordings. Two-electrode voltage clamp-
ing of Xenopus oocytes was performed using standard electro-
physiological procedures, using either a GeneClamp 500 amplifier or
an OpusXpress system (Axon Instruments, Inc., Union City, CA). All
experiments were performed at 22−25 °C. Glass microelectrodes were
backfilled with 3 M KCl and had a resistance of approximately 1 MΩ.
The holding potential was −60 mV. Oocytes were perfused with saline
at a rate of 4 mL/min. Extracellular saline contained (mM), 96 NaCl, 2
KCl, 1.8 mM CaCl2, 1 MgCl2, and 5 mM HEPES, pH 7.4.
Concentration−response curves and parameters were obtained using
Prism software (GraphPad, Prism v 4.0, San Diego, CA).
Values are shown for a series of experiments and presented as the
mean ± SEM. Statistical analysis was performed in Prism v4.03 using a
one-way ANOVA or Student’s t test.
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